Get started
Korro Bio, Inc.Korro Bio, Inc.Korro Bio, Inc.

Korro Bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

KRRO chart


Full chart

KRRO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪440.31 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−12.02 USD
Net income (FY)
‪−81.17 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪5.54 M‬
Beta (1Y)
3.58

Employees


Employees (FY)
101
Change (1Y)
+53 +110.42%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−803.68 K‬ USD

About Korro Bio, Inc.


Sector
Health Technology
CEO
Ram Aiyar
Headquarters
Cambridge
Website
korrobio.com
Founded
2018
FIGI
BBG00GFMTC38
Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

KRRO news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KRRO is 50.62 USD — it has increased by 3.60% in the past 24 hours. Watch Korro Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Korro Bio, Inc. stocks are traded under the ticker KRRO.
KRRO stock has fallen by −9.85% compared to the previous week, the month change is a −35.65% fall, over the last year Korro Bio, Inc. has showed a 40.96% increase.
We've gathered analysts' opinions on Korro Bio, Inc. future price: according to them, KRRO price has a max estimate of 180.00 USD and a min estimate of 105.00 USD. Watch KRRO chart and read a more detailed Korro Bio, Inc. stock forecast: see what analysts think of Korro Bio, Inc. and suggest that you do with its stocks.
KRRO reached its all-time high on Feb 8, 2021 with the price of 2,918.50 USD, and its all-time low was 9.15 USD and was reached on Oct 30, 2023. View more price dynamics on KRRO chart.
See other stocks reaching their highest and lowest prices.
KRRO stock is 9.49% volatile and has beta coefficient of 3.58. Track Korro Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Korro Bio, Inc. there?
Today Korro Bio, Inc. has the market capitalization of ‪440.31 M‬, it has decreased by −5.43% over the last week.
Yes, you can track Korro Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Korro Bio, Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
KRRO earnings for the last quarter are −2.26 USD per share, whereas the estimation was −2.53 USD resulting in a 10.55% surprise. The estimated earnings for the next quarter are −2.57 USD per share. See more details about Korro Bio, Inc. earnings.
Korro Bio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
KRRO net income for the last quarter is ‪−21.00 M‬ USD, while the quarter before that showed ‪−21.83 M‬ USD of net income which accounts for 3.79% change. Track more Korro Bio, Inc. financial stats to get the full picture.
No, KRRO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 101.00 employees. See our rating of the largest employees — is Korro Bio, Inc. on this list?
Like other stocks, KRRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Korro Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Korro Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Korro Bio, Inc. stock shows the sell signal. See more of Korro Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.